Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aspira Women's Health Inc AWH

Healthcare Medical Devices
Aspira Women's Health Inc. is engaged in the discovery, development, and commercialization of noninvasive, artificial intelligence (AI)-powered tests to aid in the diagnosis of gynecologic diseases. The Company's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their... see more

Recent & Breaking News (NDAQ:AWH)

Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)

GlobeNewswire November 27, 2023

Aspira Women's Health Reports Third Quarter 2023 Financial Results

GlobeNewswire November 13, 2023

Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch

GlobeNewswire November 9, 2023

Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023

GlobeNewswire October 31, 2023

Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research

GlobeNewswire October 25, 2023

Aspira Women's Health Establishes a New Clinical Advisory Board

GlobeNewswire October 23, 2023

Aspira Women's Health to Present at the BioVenture Nexus Conference

GlobeNewswire September 29, 2023

Aspira Women's Health Regains Nasdaq Compliance

GlobeNewswire September 13, 2023

Aspira Women's Health Announces Dr. Jody Berry as New Chief Scientific Officer

GlobeNewswire September 11, 2023

Aspira Women's Health Signs Exclusive Sample Procurement Agreement with The University of Oxford

GlobeNewswire August 31, 2023

Aspira Women's Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire August 29, 2023

Aspira Women's Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations

GlobeNewswire August 28, 2023

Aspira Women's Health® Reports Second Quarter 2023 Financial Results

GlobeNewswire August 14, 2023

Aspira Women's Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer

GlobeNewswire August 9, 2023

Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023

GlobeNewswire July 31, 2023

Aspira Women's Health Announces $4.7 Million Registered Direct Offering

GlobeNewswire July 20, 2023

Aspira Women's Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD

GlobeNewswire June 28, 2023

Aspira Women's Health Appoints Dr. Winfred Parnell to its Board of Directors

GlobeNewswire June 5, 2023

Aspira Women's Health Regained Compliance with Nasdaq's Minimum Bid Price Requirement

GlobeNewswire June 2, 2023

Aspira Women's Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment Tests

GlobeNewswire May 31, 2023